Supriya Lifescience Ltd (SPRL)

NSE


Symbol		Exchange		Currency
SPRL	·	NSE	·	INR	Real-time
SPRL	·	BSE	·	INR	Delayed

Currency in INR

SUPRIYA Pro Research

832.80

-5.40(-0.64%)

Closed·04:59:59

Fair Value

Unlock Value

Day's Range

826.50

849.80

52 wk Range

545.50

1,085.00

SPRL Income Statement

Assess the Supriya Lifescience income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the SPRL net worth.

Period Ending:

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

2025

31/03

2026

31/03

Total Revenues

aa.aa

5,300.49

4,609.38

5,703.4

6,964.85

8,278.75

Total Revenues Growth

aa.aa

-13.04%

+23.73%

+22.12%

+18.86%

Cost Of Revenues

aa.aa

2,322.31

2,342.78

2,893.61

Gross Profit

aa.aa

3,265.82

2,648.52

3,381.09

4,622.07

5,385.14

Gross Profit Growth

aa.aa

+26.43%

-18.9%

+27.66%

+36.7%

+16.51%

Gross Profit Margin %

aa.aa

57.46%

59.28%

66.36%

65.05%

Other Operating Expenses, Total

aa.aa

1,476.84

1,778.69

2,217.32

2,719.83

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	-	-	+20.44%	+24.66%	+22.66%
aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	-	-	724.21	859.5	1,023.25
aa.aa	aa.aa	aa.aa	aa.aa	465.44	628.48	896.37	1,153.38	1,412.49

Operating Income

aa.aa

1,171.68

1,602.4

2,404.75

2,665.31

Operating Income Growth

aa.aa

+36.76%

+50.07%

+10.84%

EBIT Margin %

aa.aa

38.55%

25.42%

28.1%

34.53%

32.19%

Net Interest Expenses

aa.aa

28.96

32.08

22.09

32.6

Net Interest Expenses Growth

aa.aa

+217.89%

-50.12%

-31.14%

+47.58%

Interest Expense, Total

aa.aa

-41.98

-51.49

-18.1

-27.72

Interest And Investment Income

aa.aa

70.94

83.57

40.19

60.32

Other Non Operating Expenses, Total

aa.aa

0.1

0.02

-0.01

0.08

EBT, Excl. Unusual Items

aa.aa

2,072.45

1,235.98

1,634.5

2,426.83

2,697.99

Gain (Loss) On Sale Of Assets

aa.aa

-1.11

-0.06

-0.09

Other Unusual Items, Total

aa.aa

2.38

-3.47

EBT, Incl. Unusual Items

aa.aa

2,072.45

1,656.9

2,484.8

2,747.79

EBT, Incl. Unusual Items Growth

aa.aa

+34.18%

+49.97%

+10.58%

EBT, Incl. Unusual Items Margin

aa.aa

39.1%

29.05%

35.68%

33.19%

Income Tax Expense

aa.aa

554.35

465.76

605.23

656.59

Net Income to Company

aa.aa

1,518.1

1,191.14

1,879.57

2,091.2

Minority Interest

aa.aa

Net Income

aa.aa

1,518.1

898.57

1,191.14

1,879.57

2,091.2

Net Income Growth

aa.aa

+22.83%

-40.81%

+32.56%

+57.8%

+11.26%

Net Income Margin %

aa.aa

28.64%

19.49%

20.88%

26.99%

25.26%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

1,191.14

1,879.57

2,091.2

Basic EPS - Continuing Operations

aa.aa

14.8

23.35

25.98

Basic EPS - Continuing Operations Growth

aa.aa

+32.56%

+57.8%

+11.26%

Diluted EPS - Continuing Operations

aa.aa

18.86

14.8

23.35

25.98

Diluted EPS - Continuing Operations Growth

aa.aa

+32.62%

+57.77%

+11.26%

Basic Weighted Average Shares Outstanding

aa.aa

80.48

Diluted Weighted Average Shares Outstanding

aa.aa

80.48

Dividend Per Share

aa.aa

0.8

Dividend Per Share Growth

aa.aa

+33.33%

+25%

EBITDA

aa.aa

2,136.4

1,281.38

1,752.02

2,600.9

2,941.37

EBITDA Growth

aa.aa

-40.02%

+36.73%

+48.45%

+13.09%

EBITDA Margin %

aa.aa

40.31%

27.8%

30.72%

37.34%

35.53%

EBIT

aa.aa

1,602.4

2,404.75

2,665.31

* In Millions of INR (except for per share items)

FAQ

What was Supriya Lifescience’s revenue at year end?

At the end of the last reported fiscal year, Supriya Lifescience (SUPRIYA) recorded total revenue of 8,278.75 million INR.

How much revenue did Supriya Lifescience report in the most recent quarter?

In its most recent quarterly earnings report, Supriya Lifescience posted revenue of 1,923.95 million INR.

What was Supriya Lifescience’s net income for the year?

For the full year, Supriya Lifescience reported net income of 2,091.20 million INR.

How much net income did Supriya Lifescience post in the last quarter?

In the most recent quarter, Supriya Lifescience (SUPRIYA) posted net income of 240.43 million INR.

What was Supriya Lifescience’s gross profit for the year?

Gross profit for the year was reported at 5,385.14 million INR.

How much gross profit did Supriya Lifescience generate last quarter?

Supriya Lifescience recorded gross profit of 1,360.10 million INR in its latest quarterly report.

What was Supriya Lifescience’s annual operating income?

For the full year, Supriya Lifescience (SUPRIYA) reported operating income of 2,665.31 million INR.

What was Supriya Lifescience’s operating income last quarter?

Quarterly operating income was 411.66 million INR.

What was Supriya Lifescience’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 482.68 million INR.

What was the quarter-over-quarter change in EBITDA for Supriya Lifescience?

EBITDA changed by -50.19% million INR compared to the last quarter.

What is Supriya Lifescience’s most recent gross profit margin?

The latest reported gross profit margin for Supriya Lifescience (SUPRIYA) is 70.69% million INR.

What is Supriya Lifescience’s most recent net income margin?

Net income margin based on recent financials is 12.50% million INR.

What is Supriya Lifescience’s most recent EBIT margin?

Supriya Lifescience reported an EBIT margin of 21.40% million INR based on current figures.

How did Supriya Lifescience’s revenue change compared to the previous quarter?

Revenue changed by -30.42% million INR compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Supriya Lifescience?

In the latest quarter, gross profit changed by 0.10% million INR from the previous quarter.

S&P/TSX

35,801.09

+181.06

+0.51%

S&P/TSX 60

2,135.53

+10.51

+0.49%

US 30

51,738.20

-248.1

-0.48%

US 500

7,544.70

+2.9

+0.04%

S&P 500 VIX

21.14

-0.01

-0.05%

DAX

25,945.75

-37.12

-0.14%

Dollar Index

101.685

+0.061

+0.06%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	68.82	-0.42%	11.67M
RBC	286.21	+0.80%	2.79M
TD	175.00	+0.55%	3.80M
Suncor Energy	105.50	-5.05%	5.38M
Bank of Nova Scotia	131.61	+0.43%	4.09M
Canadian Natural	75.12	-4.21%	6.87M
Manulife Financial	62.68	+0.50%	7.39M

Name	Last	Chg. %	Vol.
Mijem Newcomm Tech	0.10	+375.00%	27.00K
Longview Capital	0.04	+300.00%	1.00K
Canna 8 Investment Trust Unt	0.01	+200.00%	1.00K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Georgia Street Capital	0.27	+103.70%	2.20K
Appili Therapeutics	0.0100	+100.00%	19.25K
Waverley Pharma	0.0200	+100.00%	6.00K

Name	Last	Chg. %	Vol.
Aitenders Tech	0.10	-75.00%	4.16K
Imaging Dynamics	0.04	-70.00%	2.50K
Modern Plant Based Foods	0.070	-61.11%	2.00K
Alterego Ventures 24	0.04	-60.00%	10.00K
Regenera Insights	0.03	-54.55%	9.00K
Bright Minds Biosciences	36.98	-51.97%	2.01K
Churchill Resources	0.02	-50.00%	880.51K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	348.45	-5.65%	620.57K
Air Canada	21.09	+4.46%	3.43M
Keel Infra	2.66	-8.59%	4.28M
Hut 8	76.930	-7.16%	795.29K
Cenovus Energy Inc	42.95	-6.18%	8.25M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A Aaaaa	15.50	+59.04%	24.65
Aaaaaa Aaaa	26.08	+54.25%	40.23
A Aaaaaaaaaa A	37.14	+52.15%	56.51
Aaa Aaaaaaaaa Aaaaa	10.120	+52.10%	15.393
Aaaaaaa	18.15	+51.24%	27.45
Aaaaaa	2.0300	+51.04%	3.0661
A Aaa Aaaaa	96.94	+48.88%	144.32

Name	Last	Upside	Fair Value
A Aaaaa	15.50	+59.04%	24.65
Aaaaaa Aaaa	26.08	+54.25%	40.23
A Aaaaaaaaaa A	37.14	+52.15%	56.51
Aaa Aaaaaaaaa Aaaaa	10.120	+52.10%	15.393
Aaaaaaa	18.15	+51.24%	27.45
Aaaaaa	2.0300	+51.04%	3.0661
A Aaa Aaaaa	96.94	+48.88%	144.32

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.